John Porter

John is a professor of Haematology and Consultant Haematologist at the University College London Hospitals in London, UK, and head of the Joint Red Cell Unit for UCLH and Whittington Hospitals. He has served as scientific adviser to the British Society of Hematology, the UK Thalassaemia Society, the Thalassaemia International Federation (TIF), and to grant review and advisory panels at the NIH in Bethesda, MD, USA. He has published more than 350 peer-reviewed articles and made numerous contributions to books, as well as clinical guidelines and other medical articles. John's clinical and research focus has been treatments of thalassaemia and sickle cell disorders, with particular reference to iron overload, the mechanisms of iron chelation, the speciation and uptake of non-transferrin-bound iron (NTB) species, the molecular basis of iron homeostasis in health and disease, and the actions and toxicities of mixed-ligand chelation therapies. As world-leading hematology, KOL John brings essential practical knowledge relevant for the pipeline program SLN124.